A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants
Clinical trial NCT02440035 · COMPLETED
Trial details
- NCT number
- NCT02440035
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-21
- Primary completion
- 2016-06-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.